InvestorsHub Logo
Followers 0
Posts 138
Boards Moderated 0
Alias Born 08/12/2016

Re: None

Friday, 03/24/2017 2:41:28 PM

Friday, March 24, 2017 2:41:28 PM

Post# of 5007
There's an additional hurdle with immuno-oncology drugs:
How exactly are they to be applied?

The other self-delivering pipelines are applied by either local injection (RXI-109, anti-scarring), or topically (RXI-231, skin-lightening cosmeceutical). My guess is immuno-oncology drugs will need to be delivered systemically (ie, via the blood).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News